Management of Patients Co- infected with HCV and HIV: A Close Look at the Role for DAAs Susanna Naggie, MD Assistant Professor of Medicine Division of.
Sponsored for CME credit by Rush University Medical Center
Post Conference Update 48 th Annual Meeting of the European Association for the Study of the Liver Sponsored for CME credit by Rush University Medical.
HCV 2014 and b eyond the i nterferon era
The new Treatments Dr John F Dillon. Curing one person Curing a population one person at a time.
HCV 2014 and beyond the interferon era Patrick M. Horne, MSN, ARNP, FNP-BC Assistant Director of Hepatology Clinical Research Division of Gastroenterology,
Management of Patients Co-infected with HCV and HIV: A Close Look at the Role for DAAs
C-HEP final book
The Future: Is Ribavirin Still Useful? David Nelson, MD Professor of Medicine, Microbiology, and Molecular Genetics Associate Dean, Clinical Research and.
PRIMARY CARE HEPATITIS C TREATMENT OUTCOMES USING PROJECT ECHO MODEL CHRIS BOYLE 3/26/2013 Hepatitis C.
Clinical Experience: Difficulties in Clinical Trial Design for Therapeutic Products to Treat Chronic HCV Infection John M. Vierling, M.D., F.A.C.P. Professor.
Division of Viral Hepatitis National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention HCV Testing and Linkage to Care for Persons Born from 1945.